Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2009
03/12/2009US20090069283 Potassium Channel Inhibitors
03/12/2009US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds
03/12/2009US20090069281 Ansamycin formulations and methods of use thereof
03/12/2009US20090069280 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents
03/12/2009US20090069279 Invert emulsions containing dhea
03/12/2009US20090069278 Hormonally-timed dermatological preparations
03/12/2009US20090069277 Compounds and compositions for treating infection
03/12/2009US20090069276 Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
03/12/2009US20090069275 Low flush niacin formulation
03/12/2009US20090069273 Phosphorylated pyrone analogs and methods
03/12/2009US20090069272 Composition for treating bone disorders
03/12/2009US20090069269 Oral composition containing difructose anhydride
03/12/2009US20090069268 Novel phosphoramidate compounds and methods of use
03/12/2009US20090069267 Central administration of stable formulations of therapeutic agents for cns conditions
03/12/2009US20090069266 Methods and compositions for nucleic acid transfer into cells
03/12/2009US20090069265 siRNA targeting inner centromere protein antigens (INCENP)
03/12/2009US20090069264 Toxoplasma gondii nucleic acid molecules
03/12/2009US20090069263 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof
03/12/2009US20090069262 Cationic Oligonucleotides, Automated Methods for Preparing Same and Their Uses
03/12/2009US20090069260 Method for producing a nucleic-acid-containing complex preparation
03/12/2009US20090069259 Treatment of neuropathic pain with zinc finger proteins
03/12/2009US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
03/12/2009US20090069257 Method of achieving persistent Transgene expression
03/12/2009US20090069256 Enhancing protein expression
03/12/2009US20090069255 Deuterium-enriched clarithromycin
03/12/2009US20090069254 Agent for inhibiting visceral fat accumulation
03/12/2009US20090069253 Whitening cosmetic composition containing arbutin nanoparticles
03/12/2009US20090069252 C-glycoside derivatives and salts thereof
03/12/2009US20090069250 Inhibitors of Histone Deacetylase
03/12/2009US20090069245 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
03/12/2009US20090069241 Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments
03/12/2009US20090069229 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences
03/12/2009US20090069223 Method for treatment of vascular hyperpermeability
03/12/2009US20090069222 Compounds Useful as Modulators of the Proteasome Activity
03/12/2009US20090069220 Dna-binding polyamide drug conjugates
03/12/2009US20090069213 Compositions for Improving the Health and Appearance of Skin
03/12/2009US20090068800 Method and/or system for forming a thin film
03/12/2009US20090068745 Compositions and methods for performing reverse gene therapy
03/12/2009US20090068719 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics
03/12/2009US20090068699 Use of glutaminyl cyclase inhibitors
03/12/2009US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
03/12/2009US20090068300 Pre- and post-workout formulations processes and supplement products thereby
03/12/2009US20090068295 Composition for treating cancer and method of using the same
03/12/2009US20090068290 Bifeprunox doses for treating schizophrenia
03/12/2009US20090068289 Formulation for menopausal women
03/12/2009US20090068287 Novel topical formulations of flucytosine and uses thereof
03/12/2009US20090068286 Method of treating cancer by administration of 5-substituted nucleosides
03/12/2009US20090068278 Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
03/12/2009US20090068277 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
03/12/2009US20090068276 Pharmaceutical compositions
03/12/2009US20090068274 Highly efficient delivery of a large therapeutic mass aerosol
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009US20090068269 Orally adminstrable opioid formulations having extended duration of effect
03/12/2009US20090068267 Novel Pharmaceutical Compositions
03/12/2009US20090068266 Sirolimus having specific particle size and pharmaceutical compositions thereof
03/12/2009US20090068264 Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate
03/12/2009US20090068263 Multiple unit compositions
03/12/2009US20090068262 Rapid dissolution of combination products
03/12/2009US20090068261 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles
03/12/2009US20090068257 Betulonic and betulinic acid derivatives
03/12/2009US20090068256 Encapsulation of Bioactive Complexes in Liposomes
03/12/2009US20090068255 Use of matrix metalloproteinase inhibitors in skin care
03/12/2009US20090068252 Transdermal Absorption Preparation
03/12/2009US20090068251 Methods and compositions for promoting wound healing
03/12/2009US20090068250 Bioresorbable and biocompatible compounds for surgical use
03/12/2009US20090068248 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
03/12/2009US20090068239 Refreshment towel and applied solution
03/12/2009US20090068236 Oral Cephalotaxine Dosage Forms
03/12/2009US20090068234 Methods and compositions for the treatment and prevention of cancer
03/12/2009US20090068229 Modified surface antigen
03/12/2009US20090068227 Use of neurotoxin therapy for treatment of urologic and related disorders
03/12/2009US20090068216 Modified surface antigen
03/12/2009US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
03/12/2009US20090068200 Method for Prongf Assay for in Vitro Diagnosis of Cancer in Particular Breast, Thyroid or Lung Cancer, and Therapeutic Use of Prongf
03/12/2009US20090068199 Methods for Treating and Detecting Beta-Cell Disease
03/12/2009US20090068198 Antibody and Uses Thereof
03/12/2009US20090068197 Mycobacterial disease detection, treatment, and drug discovery
03/12/2009US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents
03/12/2009US20090068191 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of the Pseudomonas Aeruginosa IATS 011 Serotype
03/12/2009US20090068190 Anti-proliferative combinations
03/12/2009US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
03/12/2009US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/12/2009US20090068180 treating rheumatoid arthritis or graft-versus-host disease, comprising administering a Sphingosine-1-phosphate lyase inhibitors such as 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime and at least one additional immunosuppressant and/or antiinflammatory agent
03/12/2009US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
03/12/2009US20090068174 Therapeutic alkaline protease compositions and use in facilitating the transport of agents across the gastrointestinal mucosal lining
03/12/2009US20090068169 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use
03/12/2009US20090068168 Substituted amino alcohols
03/12/2009US20090068163 Transgenic expression cartridges for expressing nucleic acids in the flower tissue of plants
03/12/2009US20090068161 Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
03/12/2009US20090068158 Thymidylate kinase mutants and uses thereof
03/12/2009US20090068152 Gene transfer for regulating smooth muscle tone
03/12/2009US20090068151 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
03/12/2009US20090068148 Peptides of cav2.2 that inhibit pain
03/12/2009US20090068147 Raav vector-based pro-opiomelanocortin compositions and methods of use
03/12/2009US20090068144 Tetrahydro-isoquinolin-1-ones for the treatment of cancer
03/12/2009US20090068143 Orally effective cannabinoid analogs
03/12/2009US20090068142 Compositions and methods for treating coronavirus infection and sars
03/12/2009US20090068140 Hepatitis c virus inhibitors
03/12/2009US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION
03/12/2009US20090068138 Polyglycerol anti-microbial agents and compositions
1 ... 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 ... 7860